URGO URGOTUL AG LITE BORDER 6,5 CM X 10 CM

Descriptions
Urgo Urgotul Ag Lite Border 6,5 cm x 10 cm is a thin absorbent and adhesive antibacterial plaster impregnated with silver salt. UrgoTul Ag Lite Border is indicated for the local treatment of poorly exuding wounds showing signs of local infection (ulcers, bedsores, 2nd degree burns, dermabrasions, traumatic wounds, surgical wounds, etc.).

Product benefits
All the effectiveness of TLC-Silver.
- To control the risk of infection.
- Broad antibacterial spectrum.
Clean the wound with physiological saline solution. If you have previously used an antiseptic, rinse the wound thoroughly with saline before applying Urgotul Ag Lite Border. Remove the protective wings from Urgotul Ag Lite Border. Apply Urgotul Ag Lite Border directly to the wound. Reapplications of Urgotul Ag Lite Border will be made every 1 to 3 days depending on the wound treated and its clinical course.

Precautions for use
Treatment with Urgotul Ag Lite Border will be carried out exclusively under medical supervision. Healthcare professionals should bear in mind that there is limited data on the prolonged and repeated use of silver plaster, particularly in children and neonates. In the absence of specific clinical data, the use of Urgotul Ag Lite Border during pregnancy and lactation and on neonates and premature infants is not recommended. Urgotul Ag Lite Border may adhere to surgical gloves (latex). It is therefore recommended that the gloves are moistened with physiological saline to facilitate the handling of Urgotul Ag Lite Border in this case. Use in conjunction with other treatments is not recommended. Avoid contact of the plaster with electrodes or conductive gels during measurements using electronic equipment (EEG, ECG, etc.). Do not resterilise the plaster. Single-use sterile packaging: re-use of a single-use plaster may lead to a risk of infection. Store Urgotul Ag Lite Border flat, away from moisture, light and heat (temperature below 25°C).

Contra-indications
Known sensitisation to silver or with other components of the plaster. Do not leave the plaster in place on the patient during nuclear magnetic resonance (MRI) examinations.

Composition
ready-to-use plaster, consisting of an interface combined with a thin absorbent pad and a white polyurethane backing coated with a high skin tolerance adhesive mass.

Packaging
16 plasters.